Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies.

Huang, Yue Ye

Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies. [electronic resource] - Lipids in health and disease Nov 2013 - 171 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1476-511X

10.1186/1476-511X-12-171 doi


Curcumin--therapeutic use
Fatty Acid Synthase, Type I--genetics
Fatty Liver--drug therapy
Fibric Acids--therapeutic use
Forkhead Box Protein O1
Forkhead Transcription Factors--genetics
Gene Expression Regulation
Humans
Lipid Metabolism--drug effects
Liver--drug effects
Mitochondria--drug effects
Non-alcoholic Fatty Liver Disease
PPAR gamma--genetics
Peroxisomes--drug effects
Pregnane X Receptor
Protective Agents--therapeutic use
Receptors, Cytoplasmic and Nuclear--genetics
Receptors, Steroid--genetics
Thiazolidinediones--therapeutic use